Peer-reviewed safety and efficacy
data on Electrical Twitch Obtaining Intramuscular Stimulation (eToims(R)),
successfully applied to patients suffering from treatment-resistant chronic
pain appeared in the August/September issue of Electromyography and
Clinical Neurophysiology. The findings reported by University of
Pennsylvania associated physicians Jennifer Chu, M.D. and Ira Schwartz,
M.D., Ph.D., represent an important advancement in understanding this
debilitating disease.
"Seventy-six million Americans, including Olympic athletes suffer from
constant long-standing muscle pain, for which treatment is elusive", says
Dr. Chu, Associate Professor of Physical Medicine and Rehabilitation, and
faculty at the University of Pennsylvania's Medical School for over 30
years. "This study demonstrates a ground-breaking, non-invasive and
drug-free approach that controls and may ultimately eliminate the most
common cause of muscle pain".
eToims(R)-related neuromuscular pain research began in 1990, combining
5,000-year-old art of acupuncture with modern technology applied to
anatomical and neurophysiological science. In 2006, eToims(R) became
non-invasive replacing needle use with a handheld electrical wand.
eToims(R) produces muscle twitches by stimulating deep neuromuscular
junctions at multiple body areas relieving muscle tightness,
differentiating it from all other invasive and noninvasive neuromuscular
stimulation.
The results were from 92 patients aged 20 to 82 years, with long
standing, treatment non-responsive muscle pain, who paid for ongoing
eToims(R) treatments. Pain relief was more definitive in those receiving
3Hz frequency electrical stimulation for 4 seconds than 1Hz for 1 second,
establishing the therapeutic importance of low-frequency repetitive
stimulation. There were no noted complications or adverse effects from
weekly or bi-weekly treatments applied over 18 months.
Twitch-induced pain relief results from effective internal stretching
of nerve-related, pain producing shortened muscles. The scientific deep
massage effects relax muscles, release entrapped nerves, decrease traction
on pain- sensitive structures, increase oxygen-rich blood inflow to, and
pain-producing chemical outflow from affected areas.
eToims(R) Medical Technology, LLC developed and patented the eToims(R)
system (stopmusclepain) and was recently named one of
Philadelphia's Top 3 Emerging Biotechnology Companies by Benjamin Franklin
Technology Partners. In September, the company will present at AdvaMed
2008: The MedTech Conference (advamed2008) in Washington D.C.
eToims(R) Medical Technology is expected to receive relevant U.S. and
European regulatory clearance before the end of 2008.
eToims Medical Technology
stopmusclepain